Cohen Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.43M Buy
121,990
+3,030
+3% +$80.7K 1.63% 30
2025
Q4
$2.96M Buy
118,960
+5,185
+5% +$131K 1.36% 37
2025
Q3
$2.9M Buy
113,775
+10,285
+10% +$254K 1.41% 36
2025
Q2
$2.51M Buy
103,490
+14,984
+17% +$349K 1.31% 39
2025
Q1
$2.24M Buy
88,506
+10,097
+13% +$264K 1.3% 37
2024
Q4
$2.08M Buy
78,409
+3,343
+4% +$90.7K 1.25% 38
2024
Q3
$2.17M Buy
75,066
+12,342
+20% +$360K 1.33% 37
2024
Q2
$2.08M Sell
62,724
-7,198
-10% -$198K 1.67% 26
2024
Q1
$1.94M Buy
69,922
+8,467
+14% +$235K 1.26% 40
2023
Q4
$1.77M Sell
61,455
-1,269
-2% -$38.4K 1.3% 38
2023
Q3
$2.08M Buy
62,724
+6,244
+11% +$221K 1.67% 26
2023
Q2
$2.07M Sell
56,480
-3,596
-6% -$140K 1.67% 27
2023
Q1
$2.45M Buy
60,076
+495
+0.8% +$21.4K 1.94% 20
2022
Q4
$3.05M Buy
59,581
+554
+0.9% +$26.6K 2.54% 8
2022
Q3
$2.58M Sell
59,027
-567
-1% -$27.6K 2.37% 10
2022
Q2
$3.13M Buy
59,594
+62
+0.1% +$3.16K 2.68% 6
2022
Q1
$3.08M Sell
59,532
-282
-0.5% -$14.6K 2.29% 10
2021
Q4
$3.53M Sell
59,814
-751
-1% -$37.2K 2.52% 7
2021
Q3
$2.6M Buy
60,565
+144
+0.2% +$6.38K 2% 19
2021
Q2
$2.37M Sell
60,421
-917
-1% -$35.7K 1.84% 22
2021
Q1
$2.24M Buy
61,338
+4,119
+7% +$146K 1.82% 27
2020
Q4
$2.11M Buy
+57,219
New +$2.1M 1.9% 23

Other funds holding PFE

Cohen Investment Advisors's PFE Position: Q1 2026 in Review

Cohen Investment Advisors increased its Pfizer (PFE) stake by 2.5% in Q1 2026, buying an estimated $80.7K and bringing the position to 121,990 shares worth $3.43M. The position accounts for 1.63% of the portfolio, ranked #30.

Cohen Investment Advisors first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.53M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Cohen Investment Advisors held 121,990 shares of Pfizer worth $3.43M as of Q1 2026.
  • Cohen Investment Advisors bought 3,030 Pfizer shares in Q1 2026, an estimated $80.7K.
  • Pfizer made up 1.63% of Cohen Investment Advisors's portfolio in Q1 2026, its #30 holding.
  • Cohen Investment Advisors first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • Cohen Investment Advisors's Pfizer position peaked at $3.53M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Cohen Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.